HepaTx

Biotechnology, Medical, Therapeutics
Founded in 2015-01-01
Palo Alto, California, United States
http://hepatx.com
For Profit

About HepaTx

HepaTx is developing regenerative medicine solutions to address the need for better therapies for life-threatening liver diseases. The technology invented at Stanford University enables efficient hepatocyte production for therapeutic purposes. Its therapeutics can replace lost liver function to treat those with end-stage of liver disease, potentially saving the cost and morbidity of whole organ transplant.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 2100000 USD
  • Last Funding: None (Seed)
  • Funding Status: Seed

Technology Stack

HepaTx actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Medical, Therapeutics

Headquarters: Palo Alto, California, United States